UNSPSC 51342903: Inosine pranobex

This classification denotes an immunostimulant with the molecular formula C10H12N4O5.3C9H9NO3.3C5H13NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier W1SO0V223F, chemically known as p-acetamidobenzoic salt of n,n-dimethylamino-2-propanol & inosine (3:1) np 113 but generally known as inosine pranobex, which bears US NIH Compound Identifier 37510. European Medicines Agency schedules Inosine pranobex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB14214MIG.

UNSPSC 51342903 Inosine pranobex, a Commodity code, shows minimal relevant recent activity. The four state and local opportunities tagged under this code do not align with inosine pranobex procurement; instead, they cover naloxone and drug deactivation systems (Seminole County, Florida), direct-to-manufacturer prescription programs (Texas Health and Human Services Commission), medical and first aid supplies for emergency response (City of Tampa), and generic multi-source pharmaceuticals and OTC products through cooperative purchasing (Minnesota Multistate Cooperative Purchasing Alliance). None of these solicitations target inosine pranobex specifically, indicating that the code is either misapplied to these opportunities or carries little relevant transactional activity in current state and local procurement.

The geographic spread of mislabeled opportunities spans Florida, Texas, Minnesota, and Oregon. The issuing bodies include county health departments, state health agencies, municipal fire departments, and cooperative purchasing organizations serving multiple jurisdictions. Without concrete evidence of state and local demand for inosine pranobex as a distinct procured item, the code does not support a credible business development strategy at this time.